Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000761513 | SCV001225250 | likely pathogenic | Glycogen storage disease IXc | 2023-10-16 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 157 of the PHKG2 protein (p.Glu157Lys). This variant is present in population databases (rs752961445, gnomAD 0.0009%). This missense change has been observed in individuals with clinical features of glycogen storage disease type IXc (GSDIXc) (PMID: 12930917, 25266922; Invitae). ClinVar contains an entry for this variant (Variation ID: 623365). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHKG2 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Al Jalila Children's Genomics Center, |
RCV000761513 | SCV001984633 | uncertain significance | Glycogen storage disease IXc | 2020-09-21 | criteria provided, single submitter | clinical testing | |
Department Of Genetics, |
RCV000761513 | SCV000891642 | likely pathogenic | Glycogen storage disease IXc | 2017-12-30 | no assertion criteria provided | curation |